← Leaderboards
Thomas P. Monath
Acambis, Inc.
$4,805,438
Attributed
$4,805,438
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,805,438 · 3
By mechanism
R01$2,951,659 · 1
UC1$1,827,779 · 1
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentRecombinant VirusLive VaccineFlaviviridaeLaboratory MouseYellow FeverZoonosisEncephalitis VirusEpizootiologyGenetic ManipulationOral AdministrationAttenuated MicroorganismViral VaccinesDengue VirusClinical Trial Phase IBiotechnologyWest Nile VirusMacaca MulattaDengue
Grant awards (5)
LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS$1,577,110
R01 · FY2002 · AI
LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS$1,111,767
R01 · FY2001 · AI
Chimeric yellow fever 17D/Dengue vaccines$1,827,779
UC1 · FY2000 · AI
LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS$262,782
R01 · FY2000 · AI
CHIMERIC YELLOW FEVER 17D/DENGUE AND WEST NILE VACCINES$26,000
RC1 · FY2000 · AI